Follow on Google News News By Tag Industry News News By Location Country(s) Industry News
Follow on Google News | John Fowler of JACA Architects Attends Pharmacy Compounding ConferenceBy: JACA Architects CriticalPoint organized this program in partnership with the Massachusetts Hospital Association (MHA) in part due to the new training requirements for all licensed compounding pharmacies regarding sterile/non- “The program reinforced my understanding of the current regulations and forthcoming changes to the USP and Massachusetts Board of Pharmacy requirements and also best practices that I’m sharing with my colleagues and clients,” said Fowler. “Going beyond the physical design requirements to understanding the work processes and numerous challenges facing pharmacists allows for a deeper dialogue during the design process and ultimately a better pharmacy.” “It’s important for us as healthcare-focused architects to understand on a deeper level the types of challenges that specific medical facilities potentially face,” said Tony Cavallaro, president of JACA Architects. “Attending a conference like this is a great way for us to gain additional information directly from people in the field, and we are glad that John represented us at this recent event.” About JACA Architects JACA Architects is a 24-employee healthcare architectural firm founded in 1991 by Anthony Cavallaro, AIA, who serves as the company’s president and Chief Executive Officer. JACA focuses its practice exclusively in the field of healthcare and medical design. JACA’s design work can be seen in many healthcare facilities throughout the region. A partial list of clients includes Beth Israel Deaconess Medical Center, Lahey Health, Southcoast Health, and Cape Cod Healthcare. The firm’s design expertise includes operating rooms, clinics, hospitals, physicians’ offices, and all aspects of healthcare design. JACA maintains offices at 9 Billings Road, North Quincy, MA. For additional information on the firm, please visit www.jacaarchitects.com or call (617) 769-6300. End
Account Email Address Account Phone Number Disclaimer Report Abuse
|
|